Evidence map›Paper›PMID 30713929›Full record

ArticleMovement disorders clinical practice

Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes.

Eva Reiter, Beatrice Heim, Christoph Scherfler, Christoph Mueller, Michael Nocker, Jean-Pierre Ndayisaba, Wolfgang Loescher, Klaus Seppi, Andrew J Lees, Thomas Warner and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Movement disorders clinical practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epileptic Vertigo and Nystagmus in Cerebral Hemiatrophy Syndrome.Journal of clinical neurology (Seoul, Korea) · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Eva ReiterDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Beatrice HeimDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Christoph ScherflerDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Christoph MuellerDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Michael NockerDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Jean-Pierre NdayisabaDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Wolfgang LoescherDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Klaus SeppiDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Andrew J LeesDepartment of Molecular Neuroscience and Reta Lila Weston Institute for Neurological Studies University of London London United Kingdom.
Thomas WarnerDepartment of Molecular Neuroscience and Reta Lila Weston Institute for Neurological Studies University of London London United Kingdom.
Werner PoeweDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Gregor K WenningDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Atbin DjamshidianDepartment of Neurology Innsbruck Medical University Innsbruck Austria.
Innsbruck Medical University · ATUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCerebral hemiatrophy syndromes can present with variable neurological symptoms. In childhood epilepsy, mental retardation and neuropsychiatric disorders are common while in adults movement disorders, such as highly asymmetric parkinsonism or hemidystonia as well as neuropsychiatric problems have been reported.

methodsHere, we present three adult patients with features that expand the clinical spectrum and give an overview of the most common clinical signs associated with this rare condition.

resultsAll three patients had prominent neuropsychiatric symptoms such as mood swings and increased irritability. Furthermore, one patient developed hemichorea which can be a rare presentation of cerebral hemiatrophy.

conclusionsCerebral hemiatrophy syndromes are a heterogeneous group of disorders that may also present with neuropsychiatric symptoms or hemichorea.

Indexed as

apomorphinecerebral hemiatrophy syndromehemichoreaimagingneuropsychiatric symptoms

Identifiers

PMID30713929
PMCPMC6353474
OpenAlexW2478834106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.